Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma
Clinical trial NCT01846390 · COMPLETED
Trial details
- NCT number
- NCT01846390
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2016-07-06
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.